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Background-—Varying degrees of co-occurrence of intracranial aneurysms (IA) and aortic aneurysms (AA) have been reported. We
sought to compare the risk for AA in fusiform intracranial aneurysms (fIA) and saccular intracranial aneurysms (sIA) disease and
evaluate possible genetic connection between the fIA disease and AAs. Additionally, the characteristics and aneurysms of the fIA
and sIA patients were compared.
Methods and Results-—The Kuopio Intracranial Aneurysm Database includes all 4253 sIA and 125 fIA patients from its Eastern
Finnish catchment population, and 13 009 matched population controls and 18 455 first-degree relatives to the IA patients were
identified, and the Finnish national registers were used to identify the individuals with AA. A total of 33 fIA patients were studied
using an exomic gene panel of 37 genes associated with AAs. Seventeen (14.4%) fIA patients and 48 (1.2%) sIA patients had a
diagnosis of AA. Both fIA and sIA patients had AAs significantly more often than their controls (1.2% and 0.5%) or relatives (0.9%
and 0.3%). In a competing risks Cox regression model, the presence of fIA was the strongest risk factor for AA (subdistribution
hazard ratio 7.6, 95% CI 3.9–14.9, P<0.0005). One likely pathogenic variant in COL5A2 and 3 variants of unknown significance
were identified in MYH11, COL11A1, and FBN1 in 4 fIA patients.
Conclusions-—The prevalence of AAs is increased slightly in sIA patients and significantly in fIA patients. fIA patients are older and
have more comorbid diseases than sIA patients but this alone does not explain their clinically significant AA risk. ( J Am Heart
Assoc. 2019;8:e013277. DOI: 10.1161/JAHA.119.013277.)
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A neurysmal subarachnoid haemorrhage at an incidence of7.9 per 100 000 and in an average age of 50 to
60 years,1 is a devastating form of stroke: 20% of aneurysmal
subarachnoid haemorrhage patients die instantly2 and, when
admitted alive, up to 30% within 12 months.3 In most cases,
the cause is rupture of a saccular intracranial aneurysm (sIA),
formed during life in some 3% of general population.4 Risk
factors for sIA include age, female sex, smoking, hyperten-
sion, sIA family history, and polycystic kidney disease.5
Fusiform IAs (fIAs), like aortic aneurysms (AA), are dilatations
of arterial segments6,7: fIAs are uncommon, and remain poorly
characterized and difficult to treat.7
Aortic aneurysms (AA) are increasingly prevalent amongst
aging population especially in aging, smoking, hypertensive
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men.8–10 The incidence varies from 6 to 10.4 per 100 000 for
thoracic aortic aneurysms (TAA)8 to 0.89 to 176.08 per
100 000 for abdominal aortic aneurysms (AAA), the preva-
lence increasing steeply towards the most aged groups.11
Familial background precedes 20% of thoracic aortic aneur-
ysms (TAA) and positive family history is a known risk factor
for abdominal aortic aneurysm (AAA).8–10
Increased prevalence of IA in AA patients, as well as AA in
IA patients, has been suggested in several studies.12–19
However, these cohorts did not contain patients and controls
from defined catchment populations and, in most cases, fIAs
were not distinguished from sIAs.
We analyzed, in retrospect, the characteristics of the
125 fIA patients with 134 fIAs as compared with the 4253
sIA patients with 6097 sIAs from a defined population in
the Kuopio Intracranial Aneurysm Patient and Family
Database, which comprises all the IA patients of Eastern
Finland diagnosed or treated in Kuopio University Hospital
(KUH) since 1980. We studied the prevalence of AA in
these fIA patients and sIA patients and in their first-degree
relatives, and in the patients’ matched population controls,
using the Finnish national clinical registries. Hypothesizing
that fIAs and AAs, both fusiform in shape, share genomic
risk factors, we systematically reviewed the literature for
family trees containing IA and AA patients and for patient
cohorts with patients with both IA and AA. Finally, we
sequenced 33 fIA patients with an aortic gene panel of 37
AA-related genes.
Methods
Data that support the findings of this study are available to
qualified researchers who meet the criteria provided by the
board of the Kuopio Intracranial Aneurysm Patient and Family
Database.20 The Finnish National Institute for Health and
Welfare provides data for all researchers who meet the
criteria set by the institute.
KUH Catchment Population
KUH Neurosurgery has been a sole provider of full-time acute
and elective neurosurgical services for the KUH catchment
population in Eastern Finland since 1977. Between 1980 and
2015, the geographic area of the KUH hospital districts did
not change, the population decreased from 882 671 to
815 021, the median age increased from 37 to 42 years in
men and from 40 to 45 years in women whereas the
proportion of men has remained at 49%.21,22
Kuopio IA Patient and Family Database
The database includes all cases of unruptured and ruptured IA
patients admitted to KUH since 1980 for angiography and
treatment, unless moribund or very aged. The database has
been prospective since 1990. The database is administrated
by a full-time nurse coordinator who interviews all new
patients and codes this information, including family history,
and the clinical data from hospital periods and follow-up visits
into an extensive list of variables. The criterion for familial IA
disease was at least 2 affected first-degree relatives. The
genealogy of the verified IA patients has been extensively
mapped through parish records up to the 17th century.22 The
phenotype, concomitant diseases, genetics, and outcome of
Eastern Finnish sIA patients have been analyzed in several
studies.21–25
Study Population
The Kuopio IA Database includes only patients with intracra-
nial aneurysm(s) in 4-vessel angiography (digital subtraction
angiography, computed tomography angiography, or magnetic
resonance angiography), initially verified by both a neurovas-
cular neurosurgeon and a neuroradiologist. The 125 fIA
patients were agreed to carry a fusiform or dolichoectatic
aneurysm in a re-review by a neurosurgeon (B.R.J.) and an
interventional neuroradiologist (O.T.) (Figure 1). Intracranial
artery dissections were excluded. The size of the fIAs was
Clinical Perspective
What Is New?
• Prevalence of diagnosed aortic aneurysms in patients with
intracranial aneurysms, assessed through the Finnish
nationwide diagnosis register, is increased in comparison
to the matched population controls and first-degree
relatives of the patients with intracranial aneurysms.
• Patients with fusiform intracranial aneurysms, constituting
3% of all patients with intracranial aneurysms, are older and
have a greater burden of comorbid diseases and cardiovas-
cular risk factors in comparison with patients with saccular
intracranial aneurysms.
• Presence of a fusiform intracranial aneurysm is strongly
associated with aortic aneurysms, independent of other
investigated cardiovascular risk factors.
What Are the Clinical Implications?
• Fusiform intracranial aneurysms are associated with a
clinically significant co-occurrence rate of aortic aneurysms,
and we recommend screening patients with fusiform
intracranial aneurysms for aortic aneurysms.
• Saccular intracranial aneurysm patients share risk factors
with aortic aneurysm patients, but routine screening does
not seem to be indicated because of low co-occurrence rate.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 2
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defined as the greatest length or largest perpendicular
diameter, whichever larger.
A total of 450 and 17 825 first-degree relatives were
identified to the 125 fIA patients and the 4253 sIA patients,
respectively, using the personal identity codes and the Finnish
Population Register Centre (Figure 2).22,25 A total of 340 and
12 669 matched population controls were assigned to the 125
fIA patients and the 4253 sIA patients, matched by age, sex,
year, andmunicipality at the IA diagnosis. The index date for the
matching was the date of the admission for IA or aneurysmal
subarachnoid haemorrhage, with all controls alive at that point.
Although we aimed at a 3:1 ratio (controls:patients), this ratio
was not achieved in 35 fIA and 90 sIA patients.
Data Fusion From National Registries With
Personal Identification Codes
The drugs prescribed for the patients, the family members and
the controls, purchased from apothecaries, as well as the
hospital diagnoses and the causes of death were imported
from the Finnish national registries.20 The Finnish electronic
hospital diagnosis registry (Care Register for Health Care
HILMO, managed by the Finnish Institution for Health and
Welfare), which was cross-linked with the Kuopio IA Database,
covers all secondary and tertiary centers in Finland and
includes all medical specialties. The hospital diagnoses from
1969 to 2014 and medication reimbursement statistics from
1995 to 2014 were available.
The prevalence of hypertension and atherosclerotic disease
were investigated with both the hospital discharge register and
the national medicine reimbursement statistics. Hypertension
was defined as either: (1) diagnosis of hypertension or
hypertensive disease in the diagnosis registry; or (2) use of
prescribed antihypertensivemedication (ATC codesC02, C03A,
C04, C08 and C09). The general limit for diagnosis of
hypertension has been ≥ 140/ ≥ 90 mm Hg during the time
period covered by the study. Atherosclerotic disease and
hyperlipidemia were defined as either: (1) diagnosis of
atherosclerotic disease (peripheral atherosclerosis, atheroscle-
rotic heart disease, atherosclerotic disease of cerebral arteries);
or (2) use of prescribed lipid-lowering drugs (ATC code C10).
Diagnosed Aortic Aneurysms in the Study
Population
The diagnosed aortic aneurysms in the 4378 IA patients and
their 17 278 first-degree relatives and 13 009 population
controls were obtained from the Finnish national hospital
discharge register (Care Register for Health Care). The Interna-
tional Classification of Diseases, Ninth Revision (ICD-9) and ICD-
10 codes for aortic dissections and aneurysm (441.0–441.9
and I71.00–I71.9.) were used. Furthermore, the chest radio-
graphs, as well as thoracic and abdominal computed tomog-
raphy (CT) or ultrasound imaging available for 80 (64%) fIA
patients were re-reviewed by a neurosurgeon (B.R.J.) and an
interventional radiologist (H.M.) for presence of aortic aneur-
ysms. The patient records of the IA patients with AA or
dissection were obtained whenever possible to ascertain the
diagnosis and the type of AA.
Genotyping With Aortic Aneurysm Gene Panel
Of the 41 fIA patients alive, 33 were available for genotyping
with informed and signed consent. Four of these 33 patients
were diagnosed with AA. First-degree relatives of the patients
were not available for screening. Targeted sequencing was
performed using OS-seq technology described earlier26,27
using a commercial Aorta Panel consisting of 37 AA genes:
ABCC6, ACTA2, ADAMTS2, CBS, COL1A1, COL1A2, COL2A1,
COL3A1, COL5A1, COL5A2, COL9A1, COL9A2, COL11A1,
COL18A1, EFEMP2, ELN, ENPP1, FBLN5, FBN1, FBN2,
FKBP14, FLNA, GATA5, MFAP5, MYH11, NOTCH1, PLOD1,
SKI, SLC2A10, SLC39A13, SMAD3, TGFB2, TGFB3, TGFBR1,
TGFBR2, TNXB, ZNF469 (www.blueprintgenetics.com). All
protein coding exons and exon-intron boundaries (15 bps)
are covered in each targeted gene and the panel has high
sensitivity to detect single nucleotide variants, small inser-
tions and deletions up to 50 bps as well as exon level copy-
number variations. Variant classification followed the 2015
ACMG (American College of Medical Genetics and Genomics)
guideline.28
Figure 1. The major intracranial extracerebral arteries with the
circle of Willis (middle). The saccular intracranial aneurysm (left
upper) forms at the branching sites of the arteries, whereas the
uncommon fusiform intracranial aneurysm (right upper) mainly
involves the arterial trunks (see Figure 5). The dolichoectasia
(right lower) usually involves the vertebrobasilar trunk. The acute
dissection with false lumen (left lower), more frequent in the
cervical arteries, is also shown. Note the atheromatous plaque of
the fusiform intracranial aneurysm wall and the calcification of the
dolichoectatic artery. IA indicates intracranial aneurysm.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 3
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Shortly, pathogenicity of the identified variants were
assessed by considering the predicted consequence, the
biochemical properties of the codon change, the degree of
evolutionary conservation as well as a number of reference
population databases and mutation databases such as, but
not limited, to the 1000 Genomes Project, gnomAD, ClinVar
and the Human Gene Mutation Database. For missense
variants, in silico variant prediction tools such as SIFT,
PolyPhen, MutationTaster were used to assist with variant
classification.
Statistical Analysis
Categorical variables were compared between groups with
v2 and Fisher exact tests as appropriate. Continuous
variables were tested with the Student t-test or Mann-
Whitney U test as appropriate. As aortic aneurysms and
death might share risks factors, competing risks multivari-
ate Cox regression was performed to determine risk factors
for the diagnosis of aortic aneurysms among patients with
IA. The variables used in the model were sex, hypertension,
any diagnosed atherosclerotic disease or prescribed lipid-
lowering drug, type 2 diabetes mellitus, IA rupture status,
and IA morphology. Schoenfeld residuals were used to
confirm the model’s assumption of proportionality. The
results are expressed as subdistribution hazard ratios
(SHRs) with 95% CIs. Two-tailed P<0.05 was considered
significant.
Analyses were performed using IBM SPSS Statistics,
version 22.0 (IBM SPSS, Armonk, NY) and the R environment
for statistical computing, including cmprsk library.
Literature Review
Two literature searches were performed in September 2018
for English articles published between 1995 and 2016, a
period of non-invasive IA imaging by CT and magnetic
resonance (MR). Firstly, all cohorts with concurrent IA and
AA were searched with the terms: (aneurysm OR doli-
choecta*) AND (aorta OR aortic OR abdominal OR thoracic)
AND (intracranial OR cerebral OR cns OR brain OR subarach-
noid*) AND (prevalen* OR inciden* OR epidemiology OR
population). This gave 3969 hits). All abstracts were reviewed,
and the case reports and duplicates were excluded. The
remaining articles were searched for cohorts that reported the
angiographically identified IAs in the patients with diagnosed
AA and cohorts that reported diagnosed AAs in the patients
with IA. The final 8 cohorts presented the proportion of IAs
among the AA patients or AAs among the IA patients
(Figure 3, Table 1).12–19
Figure 2. Flowchart of the study population: 4378 patients with intracranial aneurysm (IA) disease
admitted to the Kuopio University Hospital with an unruptured IA or first aneurysmal subarachnoid
hemorrhage from the Eastern Finnish catchment population from 1980 to 2015. A total of 450 and 17 825
first-degree relatives were identified to the 125 patients with fusiform IA and the 4253 patients with
saccular IA, respectively, using the personal identity codes and the Finnish Population Register Centre. A
total of 340 and 12 669 matched population controls were assigned to the 125 fusiform IA patients and the
4253 saccular IA patients, matched by age, sex, year, and municipality at the IA diagnosis. In 35 fusiform IA
patients and 90 saccular IA patients, the 3:1 ratio was not achieved. AA indicates aortic aneurysm; AAA,
abdominal aortic aneurysm; IA, intracranial aneurysm; KUH, Kuopio University Hospital; TAA, thoracic aortic
aneurysm; undefined AA, AA of undefined site.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 4
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Secondly, all illustrated IA family trees with co-occurrence
of AA and AA family trees with co-occurrence of IA were
searched with the terms: (intracranial OR cerebral OR cns OR
brain OR subarachnoid*) AND (aortic OR aorta) AND
aneurysm* AND (gene OR genetic* OR genome OR family
OR famili* OR kindred OR generation OR hereditary OR
heritable OR inherited OR phenotyp* OR mutation* OR
variant* OR polymorphism OR linkage OR chromosomal). This
gave 314 articles. Some family trees seemed to be duplicates
but were not separable by the available data, and may
consequently be counted twice, and some did not differen-
tiate saccular IAs from other types of IAs. The final 8 cohorts
presented 27 family trees (Figure 4, Table 2).29–37
Ethical Approvals
The Kuopio IA Patient and Family Database has been approved
by the Research Ethics Committee the KUH, the Finnish
Ministry of Social Affairs and Health, and the National Institute
for Health and Welfare. Written informed consent was obtained
from all the IA patients registered to the database.
Results
Our Study Population
There were 125 patients with 134 fIAs and 4253 patients with
6097 sIAs (Figures 2 and 5, Tables 3 and 4). Of the 125 fIA
patients, 22 (18%) carried also sIAs. For the 125 fIA patients,
there were 450 first-degree relatives and 340 matched
population controls, and for the 4253 sIA patients 17 825
first-degree relatives and 12 669 matched controls (Figure 2,
Table 3).
Comparison of fIA Patients and sIA Patients
Aneurysmal subarachnoid haemorrhage had occurred in 26%
of the 125 fIA patients and 69% of the 4253 sIA patients
(P<0.0005) (Table 3). Other clinically notable differences
between the fIA and sIA patients were: age at diagnosis of IA
(median 64 and 54 years, P<0.0005); male predominance
(52% versus 45%, P=0.11); multiple fIAs versus multiple sIAs
(6% versus 28%, P<0.0005); hypertension (91% versus 75%,
P=0.001); and type 2 diabetes mellitus (22% versus 13%,
P=0.012). However, autosomal dominant polycystic kidney
disease occurred equally often (2% versus 1%, P=0.663). None
of the fIA patients with autosomal dominant polycystic kidney
disease had concurrent sIA. There were both fIA and sIA
patients who belonged to an sIA family (6% versus 14%,
P=0.007). No patients with a diagnosis of Marfan syndrome,
Loeys-Dietz syndrome, or Ehlers-Danlos syndrome were
identified in either patient group.
Comparison of fIAs and sIAs
In a comparison of the 134 fIAs and 6097 sIAs, including the
sIAs of the 22 fIA patients with both fIA and sIA, the largest
sizes of the 102 unruptured fIAs were significantly larger than
those of the 3145 unruptured sIAs (17 mm versus 4 mm,
P<0.0005). The 32 ruptured fIAs were significantly larger than
the ruptured 2952 sIAs as well (10 mm versus 7 mm,
P=0.01). Among the unruptured IAs, the 102 fIAs preferred
the arterial trunks of vertebrobasilar tree (59%) and the trunk
of the internal carotid artery (ICA) (23%) whereas the 3145
sIAs were most frequent on the middle cerebral artery
bifurcation (45%) and the intracranial ICA (25%) (Figure 5,
Table 4). Among the ruptured IAs, the 32 fIAs preferred the
vertebrobasilar artery trunks (50%) and the ICA trunk (25%)
while the 2925 sIAs were most frequent on the middle
cerebral artery bifurcation (33%) and the anterior communi-
cating artery (31%) (Figure 5, Table 4).
Figure 3. Literature search for patient cohorts with concurrent
intracranial aneurysms and aortic aneurysms. AA indicates aortic
aneurysm; IA, intracranial aneurysm.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 5
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In the 125 fIA patients, 29 fIAs (23%, median size 32 mm)
caused symptoms of brain or cranial nerve compression in
contrast to only 54 (1.3%, median size 28 mm) sIAs in the 4253
sIA patients (Table 3). Of all 67 basilar trunk fIAs, 18 (27%,
median size 38 mm) caused brainstem compression and 3
obstructive hydrocephalus. In the anterior circulation, 2 symp-
tomatic fIAs were on themiddle cerebral artery and 6 on the ICA.
AA in 125 fIA Patients
There were 17 (14%) fIA patients with a diagnosed AA (4 TAA, 12
AAA) or suspected AA (4 widened thoracic aortas in chest
radiographs [2 patients] or thoracic echocardiographs [2
patients] indicative of TAAs) and 1 patient with an aortic
dissection (Figure 2, Table 3). Of the 17 AAs, 3 (17%) had
ruptured. Of the 17 patients, 12 (71%) were men, 16 (94%) had
diagnosed hypertension, and 9 (53%) had diagnosed atheroscle-
rotic disease. The median ages at the diagnosis of fIA and AA
were 64 and 63 years (Figure 6A); in 8 patients, the AA
diagnosis preceded the fIA diagnosis. The 125 fIA patients had
significantly more often AA than their 450 first-degree relatives
(14% versus 0.9%, P<0.0005) and their 340matched population
controls (14% versus 1.2%, P<0.0005) (Table 3).
AA in 4253 sIA Patients
There were 48 (1.1%) sIA patients with diagnosed AA (37 AAA,
10 TAA, 1 undefined AA) and 2 patients with diagnosed aortic
dissection (Figure 2, Table 3). Of the 48 AAs, 8 (17%) had
ruptured. Of the 48 patients, 37 (79%) were men, 46 (96%) had
diagnosed hypertension, and 22 (48%) had diagnosed
atherosclerotic disease. The median ages at the diagnosis of
Table 1. Published Relevant Cohorts of Patients With Intracranial Aneurysms and Aortic Aneurysms
Reference Number of Patients Imaging Modality Proportion of Patients With Both IA and AA
IA patients with AAs
Flemming et al12 2005 159 patients with fIA or dolichoectasia* Not reported AAA 29/159 (18%)
sIA 16/159 (10%)
Miyazawa et al13 2007 181 IA patients† Abdominal ultrasound AAA 13/181 (7%)
Goyal et al15 2015 317 IA patients† TTE or TEE TAA 15/317 (5%)
Brinjikji et al18 2016 139 patients with vertebrobasilar
dolichoectasia†
25 with diffuse intracranial dolichoectasia†
Not reported AAA 12/139 (14%) AAA 10/25 (63%)
AA patients with IAs
Kuzmik et al14 2010 212 TAA patients 52 retrospective
and 160 prospective
MRA or CTA IA† 9/52 (17%) and IA† 10/160 (6%)
Lee et al19 2017 133 AA patients 25 aortic
dissection patients
MRA or CTA sIA 25 and fIA 2/133 (20%)
sIA 8/25 (30%)
Shin et al16 2015 660 AA patients MRA or CTA IA 71/660 (12%) fIAs excluded
Rouchaud et al17 2016 1081 AA patients CTA or MRA or DSA sIA 128/1081 (12%) 20
dissections or fIAs excluded
CTA indicates computed tomography angiography; fIA, fusiform intracranial aneurysm; DSA, digital subtraction angiography; MRA, magnetic resonance angiography; sIA, saccular
intracranial aneurysm; TEE, transoesophageal echocardiography; TTE, transthoracic echocardiography.
*Partially same patient cohort.
†Fusiform and saccular intracranial aneurysm were not distinguished.
Figure 4. Literature search for family trees with both intracra-
nial aneurysm and aortic aneurysm patients. AA indicates aortic
aneurysm; IA, intracranial aneurysm.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 6
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sIA and AA were 57 years and 66 years (P=0.006); in 9
patients, the AA diagnosis preceded the sIA diagnosis (Fig-
ure 6B). The 4253 sIA patients had significantly more often AA
than their 17 825 first-degree relatives (1.1% versus 0.3%
P<0.0005) and their 12 669matched population controls (1.1%
versus 0.5%, P<0.0005). Diagnosed or suspected AAs were
significantly more prevalent in the 125 fIA patients than in the
4253 sIA patients (14% versus 1.1%, P<0.0005).
Multivariate Analysis of Independent Risk Factors
for AA in fIA and sIA Patients
In the multivariable regression analysis, fusiform IA morphol-
ogy (SHR 7.6, 95% CI 3.9–14.9, P<0.0005), diagnosed
atherosclerotic disease or use of lipid-lowering medication
(SHR 4.4, 95% CI 2.3–8.2, P<0.0005), and male sex (SHR 3.1,
95% CI 1.5–6.4, P=0.002) were independent risk factors for AA.
However, hypertension (SHR 6.4, 95% CI 0.9–47.2, P=0.07), type
2 diabetes mellitus (SHR 1.4, 95% CI 0.7–2.7, P=0.36), and
history of IA rupture (SHR 0.4, 95% CI 0.2–1.8, P=0.26) were not.
Sequencing of fIA Patients
Thirty-three fIA patients were sequenced using an AA gene
panel of 37 genes. Six fIA patients each carried a different rare
variant (minor allele frequency <0.01): splice-donor variant
COL5A2 c.322+1G>C (NM_000393.3), four missense vari-
ants each in one patient: SKI c.1582G>C, p.(Ala528Pro)
Table 2. Published Family Trees Including Patients With Both Intracranial and Aortic Aneurysms
Family Members IA Patients With No AA IA Patients With AA AA Patients With No IA Implicated Genes
Schievink et al29 1997 19 2 IA* 1 IA* + TAA 0
Cannon-Albright et al30 2003 69 7 IA* 0 4 AA*
Nahed et al31 2005 19 2 IA* 1 IA* + TAA 0
Kim et al32 2005 28 4 IA* 0 4 AA*
16 3 IA* 0 3 AA*
24 4 IA* 0 2 AA*
22 3 IA* 1 IA* + AA* 1 AA*
25 5 IA* 0 1 AA*
16 1 IA* 0 10 AA*
Regalado et al33, 34 19 1 IA* 1 IA* + TAA 6 TAA
32 1 IA* 0 7 TAA
8 2 sIA 0 2 TAA, 3 AAA
17 1 IA* 1 IA* + TAA 4 TAA, 1 AAA
14 4 IA* 0 3 TAA
10 1 IA* 1 IA* + TAA 1 TAA, 1 AAA
6 1IA* 0 2 TAA
6 1 IA* 1 IA* + TAA 2 TAA
19 2 sIA 0 6 TAA
17 2 IA* 0 2 TAA
13 2 sIA 0 2 TAA
7 1 IA* 0 2 TAA, 1 AAA
11 1 IA* 0 4 TAA
24 3 sIA 0 6 TAA
17 1 IA* 1 IA* + TAA 4 TAA, 1 AAA SMAD3
Luukkonen et al35 2012 20 1 IA 0 3 AA* NTM
Bertoli-Avella et al36 2015 23 0 IA 1 IA* + AA* 2 AA* TGFB3
Mazzella et al37 2017 22 1 fIA 0 5 TAA TGFB2
Total 523 57 IA 9 IA + AA 95 AA
AA indicates aortic aneurysm; AAA, abdominal aortic aneurysm; fIA, fusiform intracranial aneursym; sIA, saccular intracranial aneurysm; TAA, thoracic aortic aneurysm
*The distinction between fIA vs sIA or TAA vs AAA not reported.
DOI: 10.1161/JAHA.119.013277 Journal of the American Heart Association 7
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(NM_003036.3); FBN1 c.3571G>A, p.(Asp1191Asn) (NM_
000138.4); MYH11 c.4903T>A, p.Ser1635Thr) (NM_022844.
2); COL11A1 c.278G>T, p.Gly93Val) (NM_080629.2) and a
synonymous variant COL3A1 c.1038C>T, p.(Ser346=)
(NM_000090.3) (Table 5). The splice-donor variant in COL5A2
was classified as likely pathogenic. There are 21 individuals
heterozygous for the COL5A2 c.322+1G>C variant in the
Genome Aggregation Database (gnomAD, n>120 000 exomes
and >15 000 genomes). This variant affects consensus splice
site, and all 5 components of Alamut splicing software (SSF,
MaxEnt, NNSPLICE, GeneSplicer, HSF) predict that this variant
breaks the wild-type donor site but does not generate a near-by
in-frame cryptic splice site. It has been detected in clinical
testing in one affected individual by GeneDx (ClinVar 213136),
and 2 additional affected patients with either ascending aortic
dissection or multiple aneurysms including IA have been
identified by Blueprint Genetics (Juha Koskenvuo, MD PhD,
unpublished data, 2019). One of the tested healthy family
members did not carry the variant, which further supports
pathogenicity of the variant. However, variant’s allele frequency
is relatively high, at least suggesting that it may not be fully
penetrant. MYH11, COL11A1, and FBN1 variants were classi-
fied as of uncertain significance whereas SKI and COL3A1 were
deemed to be likely benign.
Literature Review
We identified 27 published family trees with co-occurrence of
IAs and AAs (Table 1). In 21 family trees the morphology of the
IAs, whether fusiform or saccular, was not reported. There were
9 IA patients with AA and 57 IA patients with no AA. There were
95 AA (58 TAA, 7 AAA, 30 unspecified AA) patients without IA.
Discussion
Comparative Characteristics of fIA and sIA
Diseases
To our knowledge, this is the first population-based study
comparing the characteristics of the fIA disease (125 patients
with 134 fIAs) and the sIA disease (4253 with 6097 sIAs).
Fusiform IAs are rare, comprising 2.2% of all IAs in our study, and
sizeable published series are few.7 Like aortic aneurysms, fIAs
are dilatations of arterial segments, while sIAs are saccular
pouches usually formed at the artery forks (Figure 1). The site
distribution of the sIAs and the fIAs differs significantly38,39: in
our study, 56.7% of the fIAs but only 7.6%of the sIAswere located
on the vertebrobasilar artery complex (Figure 5, Table 4).
The fIA patients were significantly older than the sIA
patients, less likely to present with IA rupture, and more likely
diagnosed with hypertension, type 2 diabetes mellitus,
hyperlipidemia, or atherosclerotic disease (Table 3). In the
fIA patients of this cohort, hypertension and type 2 diabetes
mellitus were even more frequent (91% and 22%) than in the
previously reported fIA cohorts.12,40,41 Autosomal dominant
polycystic kidney disease, an unusual monogenic risk factor
for the sIA disease,24 previously reported to occur in some 2%
of patients with vertebrobasilar fIAs,12 occurred equally in the
fIA and the sIA patients (Table 3). Multiple fIAs on arterial
trunks were less frequent than multiple sIAs on bifurcations
(6% versus 28%) (Table 3). In previous cohorts of patients with
Figure 5. The most common locations of the 134 fusiform
intracranial aneurysms and the 6097 saccular intracranial
aneurysms in descending order of frequency (the left side and
the right side combined). The schematic illustration of the major
intracranial arteries with the circle of Willis shows the major
arterial bifurcations and segments (compare with Figure 1.).
Anterior circulation: the internal carotid artery up to the internal
carotid artery bifurcation; A1 the proximal segment of the anterior
cerebral artery; the anterior communicating artery; A2 to A5, the
distal segments of the anterior cerebral artery; M1, the proximal
segment of the middle cerebral artery; the bifurcation of the
middle cerebral artery; M2 to M5, the distal segments of the
middle cerebral artery. Posterior circulation: the vertebral artery;
the posterior inferior cerebellar artery; the basilar artery; the
anterior inferior cerebellar artery; the superior cerebellar artery;
the basilar tip bifurcation; P1, the proximal segment of the
posterior cerebral artery; P2–P4, the distal segments of the
posterior cerebral artery; the posterior communicating artery. A1
indicates the proximal segment of the anterior cerebral artery; A2
to A5, the distal segments of the anterior cerebral artery; ACoA,
the anterior communicating artery; AICA, the anterior inferior
cerebellar artery; BA, the basilar artery; BAbif, the basilar tip
bifurcation; IA, intracranial aneurysm; M1, the proximal segment
of the middle cerebral artery; Mbif, the bifurcation of the middle
cerebral artery; M2 to M5, the distal segments of the middle
cerebral artery; P1, the proximal segment of the posterior cerebral
artery; P2–P4, the distal segments of the posterior cerebral
artery; PCoA, the posterior communicating artery; PICA, the
posterior inferior cerebellar artery; SCA, the superior cerebellar
artery; VA, the vertebral artery.
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vertebrobasilar dolichoectasia, the reported frequency of
diffuse dolichoectatic lesions has varied considerably with a
range of 16% to 45%.18,40 Different morphologies make size
comparison of the fIAs and sIAs impractical; however,
unruptured and ruptured fIAs were larger than unruptured
and ruptured sIAs (Table 4), and the pronounced size
difference underlines and explains the different rates of
aneurysm symptomaticity. Because of their larger size and
preference for the posterior fossa, the fIAs often caused
symptoms by compression: brainstem compression, cranial
nerve symptoms, and obstructive hydrocephalus.
Few studies on the histopathology and molecular biology
of the fIA wall, resected during surgery or at autopsy, are
available. In 1 study, walls of 8 fIAs displayed fragmentation
of internal elastic lamina, neoangiogenesis within thickened
intima, intramural haemorrhage and thrombus formation.42
Similar changes are observed not only in sIAs but also in
AAAs and TAAs.43–45 Fusiform IAs have been linked to
atherosclerotic risk factors, but the association of
atherosclerosis with fIAs or its role as causal factor is
complex and unclear.6
The distinctions between and the terminology of the
spectrum of conditions that manifest as different forms of
non-saccular dilatations of intracranial arteries are often
unclear. Dolichoectasia, elongation and dilatation of intracra-
nial arteries (Figure 1), is most common in the vertebrobasilar
complex.6 In neuroimaging (CT, CT angiography, MR imaging,
MR angiography, digital subtraction angiography), dolichoec-
tasia can be difficult to distinguish from fusiform IAs, and the
two may represent the same disease spectrum and patho-
genesis.6 Acute dissection is considerably less frequent in the
intracranial arteries than in the cervical arteries, and is a rare
cause of subarachnoid haemorrhage or brain infarction.46
There are data indicating that intracranial dissection may
develop into a chronic fusiform aneurysm.47
AA in fIA and sIA Patients
To our knowledge, this is also the first population-based study
to investigate the occurrence of aortic aneurysms in both fIA
and sIA patients (Figures 2 and 6), and in the first-degree
relatives and the matched population controls for the both
Table 4. Site and Size Distribution of the 134 Fusiform and the 6097 Saccular Intracranial Aneurysms
Variables













Total 102 (17 mm) 32 (10 mm) 134 (15 mm) 3145 (4 mm) 2952 (7 mm) 6097 (6 mm)
25 and 75
percentiles
9 to 35 mm 6 to 19 mm 8 to 28 mm 3 to 7 mm 5 to 11 mm 4 to 9 mm
A1 0 2 (15 mm) 2 (15 mm) 21 (3 mm) 14 (5 mm) 35 (3 mm)
ACoA 1 (15 mm) 1 (7 mm) 2 (11 mm) 390 (4 mm) 909 (7 mm) 1299 (6 mm)
A2 to A5 0 0 0 158 (3 mm) 153 (6 mm) 311 (4 mm)
ICA to ICAbif 23 (10 mm) 8 (9 mm) 31 (10 mm) 790 (4 mm) 626 (7 mm) 1416 (6 mm)
M1 to Mbif 9 (9 mm) 1 (30 mm) 10 (9 mm) 1424 (4 mm) 963 (9 mm) 2387 (6 mm)
M2 to M5 4 (7 mm) 3 (23 mm) 7 (8 mm) 113 (3 mm) 25 (6 mm) 138 (3 mm)
PCoA 0 0 0 3 (11 mm) 2 (8 mm) 5 (8 mm)
P1 1 (9 mm) 0 1 (9 mm) 14 (3 mm) 11 (6 mm) 25 (3 mm)
P2 to P4 4 (8 mm) 1 (7 mm) 5 (8 mm) 2 (13 mm) 8 (5 mm) 10 (5 mm)
BA 46 (25 mm) 6 (8 mm) 52 (25 mm) 131 (7 mm) 134 (9 mm) 265 (8 mm)
SCA 1 (8 mm) 0 1 (8 mm) 54 (3 mm) 25 (7 mm) 79 (4 mm)
AICA 0 0 0 0 1 (8 mm) 1 (8 mm)
PICA 6 (10 mm) 2 (9 mm) 8 (10 mm) 33 (4 mm) 67 (5 mm) 100 (5 mm)
VA 7 (28 mm) 8 (10 mm) 15 (19 mm) 9 (12 mm) 10 (9 mm) 19 (10 mm)
Others 0 0 0 3 (2 mm) 4 (8 mm) 7 (3 mm)
A1 indicates the proximal segment of the anterior cerebral artery; A2–A5, the distal segments of the anterior cerebral artery; ACoA, the anterior communicating artery; AICA, the anterior
inferior cerebellar artery; BA, the basilar artery; ICA, the internal carotid artery; ICAbif, the ICA bifurcation; M1, the proximal segment of the middle cerebral artery; M2–M5, the distal
segments of the middle cerebral artery; Mbif, the bifurcation of the middle cerebral artery; others, not classified; P1, the proximal segment of the posterior cerebral artery; P2–P4, the distal
segments of the posterior cerebral artery; PCoA, the posterior communicating artery; PICA, the posterior inferior cerebellar artery; SCA, the superior cerebellar artery; VA, the vertebral
artery.
*Median of largest sIA diameter or median of largest fIA length or diameter.
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patient groups (Figure 2, Table 3). The 125 fIA patients had
significantly more often AA than their 450 first-degree
relatives (14% versus 0.9%) and their 340 matched population
controls (14% versus 1.2%). In a recent retrospective study of
139 patients with fIA or dolichoectasia, similar proportion of
the patients (12% and 14%) had concomitant AAA (Table 1),
equal to 14% in this study. In other studies, fIAs may have
been excluded or not distinguished from sIAs (Table 1).18 The
risk of AA seems to warrant the screening of aortas of all fIA
patients with MR angiography or CT angiography.
The 4253 sIA patients had clearly fewer diagnosed AAs
during the follow-up than the fIA patients (1.1% versus 14%)
(Figures 2 and 6), but, nevertheless, more than their 17 825
first-degree relatives (1.1% versus 0.3%) and their 12 669
matched population controls (1.1% versus 0.5%) (Figure 2,
Table 3). The 48 sIA patients with AA were, on average, men,
diagnosed with hypertension, with a substantial portion
carrying atherosclerotic diseases. Despite the older age and
higher burden of comorbid diseases in the fIA patients, as
compared with the sIA patients, the fusiform IA morphology
was the most important risk factor for AA in a multivariate
model alongside the recognized risk factors, indicating that
the increased AA risk in the fIA patients is not contributable to
the traditional risk factors alone. No robust data on smoking
were available for the multivariate model. The identified risk
factors for AA in IA patients and the equivocal or protective
role of diabetes mellitus against AA are well in line with
previous research.43
Genetics of fIA Disease in Relation to AA Disease
We hypothesized that the rare fIAs share, in addition to their
fusiform shape, genomic and acquired risk factors with AAs.
In our review of the literature, we identified 27 families
containing both IA patients and AA patients (Table 2). Among
the 523 members of these families, 57 IA patients and 95 AA
(58 TAA, 7 AAA, 30 unspecified AA) patients but only 9
patients with both IA and AA were identified. In most cases,
the morphology of the IAs, whether fusiform or saccular, was
not reported. A previous meta-analysis of genome-wide
association studies (GWAS) of IA, TAA and AAA cohorts did
not find evidence for shared genetic risk of IAs, TAAs and
AAAs; however, in that study, fIA patients were not distin-
guished from the sIA patients.48 The genetics of the sIA
disease remain elusive.5
In the present study, none of the 125 fIA patients had been
diagnosed with inherited traits predisposing to AAs, including
Marfan, Loeys-Dietz, or Ehlers-Danlos syndromes. We were
unable to identify any fIA families, but 6% of the fIA patients
belonged to an sIA family. Interestingly, concomitant fIA and
sIA were seen in 18% of the fIA patients, suggesting
susceptibility of these patients to aneurysms in general.
Considerable co-occurrence of fIAs and sIAs has been
reported previously in some studies.18 We sequenced 33 fIA
patients with a panel of 37 genes associated to AA, and found
only one likely pathogenic variant (COL5A2 c.322+1G>C),
Figure 6. A, Distribution of the ages, in ascending order, of the
125 fusiform intracranial aneurysm patients (32 ruptured, 93
unruptured) at the diagnosis of the fusiform intracranial aneurysm.
The ages at the diagnosis their 17 aortic aneurysms are shown
(white circles). The lifelines of the fusiform intracranial aneurysm
patients from either diagnosis (fusiform intracranial aneurysm or
AA) until the AA diagnosis, death (without AA diagnosis, black
circles) or the last follow-up (without AA diagnosis, end of lifeline)
are shown. B, Distribution of the ages, in ascending order, of the
4253 saccular intracranial aneurysms patients (2923 ruptured,
1330 unruptured) at the diagnosis of their saccular intracranial
aneurysms. The ages at the diagnosis of their 48 aortic aneurysms
are shown (white circles). The lifelines of the saccular intracranial
aneurysm patients with diagnosed AA are omitted for the sake of
clarity. The median ages at the saccular intracranial aneurysm
diagnosis (dashed vertical line) and AA diagnosis (continuous
vertical line) are shown. AA indicates aortic aneurysm.
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which would likely predispose to classic Ehlers-Danlos
syndrome or TAA or thoracic aortic dissection.
Themolecular pathologies of TAA and AAA are divergent.49 A
substantial proportion of TAAs occur in association with a
defined genetic syndrome or an identifiable single-gene muta-
tion. A focused or genome-wide testing of the proband and, in
the case of a positive finding, the first-degree relatives, is
recommended in patients presenting with syndromic features,
positive family history or absence of traditional cardiovascular
risk factors. Even though hereditary risk to AAA is well-
established, known causative single-gene mutations are few.50
Consequently, family history affects the decision threshold of
screening for the first degree relatives of AAA patients.9
However, genetic counselling is recommended if the AAA
disease cannot be solely explained by a non-genetic cause.10
Our Strengths
Our study has several strengths. The publicly-funded Finnish
healthcare system is universal, which reduces bias to minimum
in population-based disease databases. Neurosurgery of the
Kuopio University Hospital (KUH) is the sole provider of acute
and elective neurosurgical services for Eastern Finland, includ-
ing unruptured and aneurysmal SAH patients. The Kuopio IA
Patient and Family Database has incorporated clinical data for
both the IA patients and their relatives and matched population
controls from the national registries, using the Finnish personal
identity codes. The data quality of the Finnish national health
registers has been shown to be good.51
Our Limitations
However, the study has some limitations. Aortic aneurysms
have not been screened in Finland either on a population level,
in patients with intracranial aneurysms or in patients with
stroke. Unruptured IAs, with an estimated lifetime prevalence of
2% to 3%, and AAs, with an estimated lifetime prevalence of 1%
to 8%, are increasingly diagnosed as incidental findings in the
imaging of the head or the body for other reasons in the elderly
population. As both sIA and fIA patients may have had
shortened survival, their controls may have accrued longer
follow-upwith age-related increasing prevalence of AA, possibly
leading to some attenuation in our finding of increased AA
prevalence in IA patients. Our data contained 68 AAs in IA
patients but only 67 could be accurately verified. Consequently,
our available data did not allow exact anatomical classification
of all the AAs. Furthermore, the specificity of chest radiograph
for TAA, used in 2 fIA patients as the basis diagnosis, is not high
enough for definite diagnosis of TAA. The determination of the
disease status of the comorbid diseases was in many cases
based onmedication use without knowledge of the indication of
the prescription. Among the 125 fIA patients, only a small
subgroup was available for the genotyping. The genotyping
included only genes the mutations of which are known to
associate with AA.
Suggested Further Research
Fusiform IAs that involve perforators, branches and bifurca-
tions of the cerebral arteries are difficult to treat with the
present microsurgical, endovascular and bypass techniques.52
Since fIAs and AAs share the fusiform shape and, possibly,
pathogenetic mechanisms, and as fIAs and AAs partially co-
occur, cellular and molecular biology data from AA walls may
help to develop pharmacological treatment that would
stabilize the fIA wall and reduce its growth. In sIA patients,
the risk of AA diagnosis was low in our study, and may not
justify screening for AA of sIA patients, but it remains an
underestimate in the absence of prospective screening
studies of sIA patients for incidental AA.
Conclusions
In our study, without any screening for AA, 1% of the sIA
patients had diagnosis for AA, in contrast to 0.3% of their first-
degree relatives and 0.5% of their matched population
controls. These data suggest that screening for AA in sIA
Table 5. Rare Variants Found Among 33 Patients With Fusiform Intracranial Aneurysm in the Genetic Screening of 37 Genes
Associated With Aortic Aneurysms
Gene Effect on Genomic DNA Effect on Protein Transcript Allele Frequency in gnomAD Predicted Functional Consequence Clinical Significance
SKI c.1582G>C p.(Ala528Pro) 7.68e-05 Missense variant Likely benign
FBN1 c.3571G>A p.(Asp1191Asn) 1.08e-05 Missense variant VUS
COL3A1 c.1038C>T p.(Ser346=) 3.97e-05 Synonymous variant Likely benign
MYH11 c.4903T>A p.(Ser1635Thr) 0 Missense variant VUS
COL11A1 c.278G>T p.(Gly93Val) 0 Missense variant VUS
COL5A2 c.322+1G>C N/A 7.58e-05 Splice donor variant Likely pathogenic
gnomAD indicates a reference database of exomic sequences; VUS, variant of unknown significance.
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patients is not generally indicated. In fIA patients the risk of
AA was 14%. This warrants screening of aortas of all fIA
patients with MR angiography or CT angiography. The AA gene
panel with 37 previously known AA-associated genes in 33 fIA
patients identified likely disease-causing variant only in 1/33
(3%) of the patients. This observation suggests that fIA and AA
may share genetic background in some cases, but larger
cohorts are needed to validate or dispute this association.
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